DE3223499T1 - Quaternary piperidinium halides - Google Patents

Quaternary piperidinium halides

Info

Publication number
DE3223499T1
DE3223499T1 DE823223499T DE3223499T DE3223499T1 DE 3223499 T1 DE3223499 T1 DE 3223499T1 DE 823223499 T DE823223499 T DE 823223499T DE 3223499 T DE3223499 T DE 3223499T DE 3223499 T1 DE3223499 T1 DE 3223499T1
Authority
DE
Germany
Prior art keywords
compound
formula
methoxybenzoyl
amino
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE823223499T
Other languages
German (de)
English (en)
Other versions
DE3223499C2 (fi
Inventor
John E Lawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DE3223499T1 publication Critical patent/DE3223499T1/de
Application granted granted Critical
Publication of DE3223499C2 publication Critical patent/DE3223499C2/de
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE823223499T 1981-01-28 1982-01-27 Quaternary piperidinium halides Granted DE3223499T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/229,244 US4321386A (en) 1981-01-28 1981-01-28 Quaternary piperidinium halides
PCT/US1982/000108 WO1982002551A1 (en) 1981-01-28 1982-01-27 Quaternary piperidinium halides

Publications (2)

Publication Number Publication Date
DE3223499T1 true DE3223499T1 (de) 1983-01-13
DE3223499C2 DE3223499C2 (fi) 1989-11-23

Family

ID=22860396

Family Applications (1)

Application Number Title Priority Date Filing Date
DE823223499T Granted DE3223499T1 (de) 1981-01-28 1982-01-27 Quaternary piperidinium halides

Country Status (19)

Country Link
US (1) US4321386A (fi)
JP (1) JPH0348904B2 (fi)
AR (1) AR230266A1 (fi)
AT (1) AT378183B (fi)
AU (1) AU551523B2 (fi)
BE (1) BE891938A (fi)
CA (1) CA1184917A (fi)
CH (1) CH651021A5 (fi)
DE (1) DE3223499T1 (fi)
DK (1) DK156649C (fi)
FI (1) FI65239C (fi)
GB (1) GB2100736B (fi)
GR (1) GR74720B (fi)
IE (1) IE52420B1 (fi)
IT (1) IT1147809B (fi)
NL (1) NL8220049A (fi)
SE (1) SE435057B (fi)
WO (1) WO1982002551A1 (fi)
YU (1) YU43063B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG176772A1 (en) * 2009-04-09 2012-01-30 Cognition Therapeutics Inc Inhibitors of cognitive decline
ES2547730T3 (es) 2009-07-31 2015-10-08 Cognition Therapeutics, Inc. Inhibidores del deterioro cognitivo
AU2012212219B2 (en) 2011-02-02 2017-03-23 Cognition Therapeutics, Inc. Isolated compounds from turmeric oil and methods of use
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
CA3061787A1 (en) 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037910A (en) * 1958-04-18 1962-06-05 Burroughs Wellcome Co Process for treatment of hypertension
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US3917679A (en) * 1974-04-12 1975-11-04 Lilly Co Eli Quaternary ammonium salts of N-dialkylaminoalkyl-N-(2-indanyl)anilines

Also Published As

Publication number Publication date
IT1147809B (it) 1986-11-26
AU8148582A (en) 1982-08-16
DK156649B (da) 1989-09-18
DK429382A (da) 1982-09-27
IE52420B1 (en) 1987-10-28
IE820191L (en) 1982-07-28
SE8205535D0 (sv) 1982-09-28
SE435057B (sv) 1984-09-03
DE3223499C2 (fi) 1989-11-23
ATA900782A (de) 1984-11-15
FI822443L (fi) 1982-07-08
CA1184917A (en) 1985-04-02
CH651021A5 (de) 1985-08-30
BE891938A (fr) 1982-07-28
GB2100736A (en) 1983-01-06
YU43063B (en) 1989-02-28
FI65239B (fi) 1983-12-30
AR230266A1 (es) 1984-03-01
SE8205535L (sv) 1982-09-28
WO1982002551A1 (en) 1982-08-05
US4321386A (en) 1982-03-23
YU19782A (en) 1985-04-30
DK156649C (da) 1990-02-05
IT8247667A0 (it) 1982-01-28
FI65239C (fi) 1984-04-10
GB2100736B (en) 1985-01-30
NL8220049A (nl) 1982-11-01
AT378183B (de) 1985-06-25
JPH0348904B2 (fi) 1991-07-25
AU551523B2 (en) 1986-05-01
JPS57502216A (fi) 1982-12-16
FI822443A0 (fi) 1982-07-08
GR74720B (fi) 1984-07-10

Similar Documents

Publication Publication Date Title
DE2024001B2 (de) Tetrahydrofurfuryloxyphenoxypropanolamine und deren pharmakologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DD202152A5 (de) Verfahren zur herstellung von phenylpiperazinderivaten
DE2657978C3 (de) Linksdrehende Enantiomere und Racemate von Trifluormethylthio(und -sulfonyl)cyproheptadinderivaten, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2407115A1 (de) Neue 1,4-dihydropyridinderivate
DD147537A5 (de) Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen
DE2524054A1 (de) 1-cycloalkylmethyl-3a-(substituiertes-phenyl)-decahydroisochinoline
DE3223499C2 (fi)
DE1925956C3 (de) 4- [3-(subst- Amino)-2-hydroxypropoxy] -1,2,5thiadiazolverbindungen und ein diese Verbindungen enthaltendes pharmazeutisches Mittel
CH631448A5 (de) Verfahren zur herstellung neuer piperazinderivate.
DE3900028A1 (de) Gegebenenfalls am phenylrest halogen- und/oder alkyl- und/oder alkoxy- oder methylendioxysubstituierte, 5,5-di-(methyl)-3-(phenylvinyl)-1-(substituiert amino-alkoxy-imino)-cyclohex-2-enderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4131584A1 (de) Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
DE2425767A1 (de) 3-alkyl-9-aminoalkyl-1,2,3,4-tetrahydrocarbazole und ihre verwendung in arzneimitteln
CH623562A5 (fi)
CH615665A5 (en) Process for the preparation of the Z-isomer of 3-(4-bromophenyl)-N-methyl-3-(3-pyridyl)allylamine
DE2903917C2 (fi)
DE2311067C2 (de) Diphenylmethoxyäthylamine, Verfahren zu deren Herstellung und Verwendung von Diphenylmethoxyäthylaminen bei der Bekämpfung der Parkinson-Krankheit
DE2425306C2 (de) Imidazolido [1,5-c] thiazolidin-3-spiro-4'- [1'-(4-p-fluorphenyl-4-oxobutyl)-piperidin] -derivate, ihre Salze, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2035535A1 (de) Eckige Klammer auf 3 Alkoxy 2 (diaryl) methyl eckige Klammer zu propylamine, ihre Herstellung und Verwendung
DE3027338C2 (de) Isochinolinderivate, ihre Salze, Verfahren zu ihrer Herstellung und therapeutische Zubereitung
DE2062055A1 (de) Propanolamin Derivate
DE2259012C3 (de) 8beta-Pvrimidyl-(2)-aminomethyl-10 a-ergolinderivate und Verfahren zu ihrer Herstellung
DE2638849A1 (de) Aminosaeureester, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE1643459C3 (de) 1 -(2-Methoxyphenoxy) -3-tert-butylamino-2-propanol und dessen Salze, Verfahren zu deren Herstellung und Arzneimittel
DE1960839C3 (de) Verfahren zur Herstellung von heterocyclischen Verbindungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BRISTOL-MYERS SQUIBB CO. (N.D.GES.D.STAATES DELAWA

8328 Change in the person/name/address of the agent

Free format text: KINZEBACH, W., DIPL.-CHEM. DR.PHIL. RIEDL, P., DIPL.-CHEM.DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee